Results 221 to 230 of about 15,171,266 (336)

[Superficial venous thrombosis, a necessary image]. [PDF]

open access: yesAten Primaria
Morena López D   +2 more
europepmc   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

[Comments on the article "Main factors associated with hypoglycemia in patients with type 2 diabetes"]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Calleja-Alarcón S   +3 more
europepmc   +1 more source

Uso problemático de internet en estudiantes universitarios : factores asociados y diferencias de género

open access: yes, 2015
Tania Fernández-Villa   +11 more
semanticscholar   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

open access: yesMolecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster   +3 more
wiley   +1 more source

Factores Protectores de Enfermedad Cardiovascular [PDF]

open access: yes, 1998
Fiol Sala, Miguel   +2 more
core  

Factor Analysis [PDF]

open access: yesBritish Journal of General Practice, 2018
openaire   +2 more sources

Home - About - Disclaimer - Privacy